Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia.

Eriksson L, Haglund B, Odlind V, Altman M, Ewald U, Kieler H.

Acta Paediatr. 2015 Mar;104(3):259-63. doi: 10.1111/apa.12888. Epub 2015 Jan 30.

PMID:
25469645
2.

Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia.

Eriksson L, Haglund B, Odlind V, Altman M, Kieler H.

Pediatr Pulmonol. 2014 Jul;49(7):665-72. doi: 10.1002/ppul.22881. Epub 2013 Sep 4.

PMID:
24039136
3.

Antibiotic prescription preferences in paediatric outpatient setting in Estonia and Sweden.

Lass J, Odlind V, Irs A, Lutsar I.

Springerplus. 2013 Mar 21;2(1):124. doi: 10.1186/2193-1801-2-124. Print 2013 Dec.

4.

[Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].

Milsom I, von Sydow H, Thörn AB, Björkelund C, Odlind V.

Lakartidningen. 2012 Sep 19-26;109(38):1680-2. Swedish. No abstract available.

PMID:
23094400
5.

Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term.

Eriksson L, Haglund B, Ewald U, Odlind V, Kieler H.

Acta Obstet Gynecol Scand. 2012 Dec;91(12):1415-21. doi: 10.1111/aogs.12014. Epub 2012 Nov 1.

PMID:
23006062
6.

Off-label drug use in pediatric patients.

Kimland E, Odlind V.

Clin Pharmacol Ther. 2012 May;91(5):796-801. doi: 10.1038/clpt.2012.26. Review. No abstract available.

PMID:
22472984
7.

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study.

Kimland E, Nydert P, Odlind V, Böttiger Y, Lindemalm S.

Acta Paediatr. 2012 Jul;101(7):772-8. doi: 10.1111/j.1651-2227.2012.02656.x. Epub 2012 Mar 24.

8.

Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study.

Olsson J, Kimland E, Pettersson S, Odlind V.

Acta Paediatr. 2011 Sep;100(9):1272-5. doi: 10.1111/j.1651-2227.2011.02287.x. Epub 2011 May 11.

9.

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.

Lambe M, Wigertz A, Holmqvist M, Adolfsson J, Bardage C, Fornander T, Karlsson P, Odlind V, Persson I, Ahlgren J, Bergkvist L.

Breast Cancer Res Treat. 2010 Jun;121(3):679-83. doi: 10.1007/s10549-009-0615-7. Epub 2009 Nov 6.

PMID:
19894110
10.

Short and long-term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm.

Eriksson L, Haglund B, Ewald U, Odlind V, Kieler H.

Acta Obstet Gynecol Scand. 2009;88(8):933-8. doi: 10.1080/00016340903111542.

PMID:
19568962
11.

Limited knowledge on progestogen-only contraception and risk of venous thromboembolism.

Bergendal A, Odlind V, Persson I, Kieler H.

Acta Obstet Gynecol Scand. 2009;88(3):261-6. doi: 10.1080/00016340902730375. Review.

PMID:
19172422
12.

Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives.

Segebladh B, Borgström A, Odlind V, Bixo M, Sundström-Poromaa I.

Contraception. 2009 Jan;79(1):50-5. doi: 10.1016/j.contraception.2008.08.001. Epub 2008 Sep 11.

PMID:
19041441
13.

Adverse mood effects of combined oral contraceptives in relation to personality traits.

Borgström A, Odlind V, Ekselius L, Sundström-Poromaa I.

Eur J Obstet Gynecol Reprod Biol. 2008 Dec;141(2):127-30. doi: 10.1016/j.ejogrb.2008.07.018. Epub 2008 Aug 28.

PMID:
18760521
14.
15.

Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls.

Borgström A, Kask K, Gulinello M, Odlind V, Sundström-Poromaa I.

Psychoneuroendocrinology. 2008 May;33(4):487-96. doi: 10.1016/j.psyneuen.2008.01.007. Epub 2008 Mar 7.

PMID:
18329179
16.

Late bleeding problems with the levonorgestrel-releasing intrauterine system: evaluation of the endometrial cavity.

Rönnerdag M, Odlind V.

Contraception. 2007 Apr;75(4):268-70. Epub 2007 Jan 26.

PMID:
17362704
17.

10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception.

Aaltonen P, Amory JK, Anderson RA, Behre HM, Bialy G, Blithe D, Bone W, Bremner WJ, Colvard D, Cooper TG, Elliesen J, Gabelnick HL, Gu YQ, Handelsman DJ, Johansson EA, Kersemaekers W, Liu P, MacKay T, Matlin S, Mbizvo M, McLachlan RI, Meriggiola MC, Mletzko S, Mommers E, Muermans H, Nieschlag E, Odlind V, Page ST, Radlmaier A, Sitruk-Ware R, Swerdloff R, Wang C, Wu F, Zitzmann M.

J Androl. 2007 May-Jun;28(3):362-3. Epub 2006 Dec 27. No abstract available.

18.

Characteristics of women at low risk of STI presenting with pelvic inflammatory disease.

Viberga I, Odlind V, Lazdane G.

Eur J Contracept Reprod Health Care. 2006 Jun;11(2):60-8.

PMID:
16854678
19.

Practices and perceptions on intrauterine contraception among Latvian obstetrician-gynecologists.

Viberga I, Odlind V, Zodzika J.

Acta Obstet Gynecol Scand. 2006;85(5):583-8.

PMID:
16752238
20.

Abortion rate and contraceptive practices in immigrant and Swedish adolescents.

Helström L, Zätterström C, Odlind V.

J Pediatr Adolesc Gynecol. 2006 Jun;19(3):209-13.

PMID:
16731415

Supplemental Content

Loading ...
Support Center